Vendor source

Reviewed 11 May 2026

Completeness Comprehensive (81%)

Neurophet AQUA

Neurophet

Neurophet AQUA is an artificial intelligence-based degenerative brain disease diagnosis assistant software that helps clinicians to diagnose brain MRI data through quantitative analysis.

Supported by 3 papers

Neurophet AQUA thumbnail 1
Neurophet AQUA thumbnail 2

Key Features

  • Brain region segmentation
  • Multi-time-point analysis.
  • Normative comparison
  • Report generation
  • Volume quantification
  • White matter hyperintensity quantification

General Information

Product name

Neurophet AQUA

Company

Modality

MR

Main task

Not specified

Subspeciality

Neuro

Disease targeted

Mild cognitive impairment, Alzheimer's disease (AD), dementia

Regulatory Information

CE Certification

Pathway:

MDD

Class:

Class IIa

Verified by Health AI Register

FDA Certification

Pathway:

510(k) cleared

Class:

Class II

Verified by Health AI Register

Other certifications

Not specified

Technical Specifications

Patient population age

Not specified

Input

3D T1 weighted image

Input format

DICOM

Output

Color-coded segmentation overlays, configurable reports with reference statistics, pre-populated radiological reporting template

Output format

DICOM

Integration

Integration in standard reading environment (PACS)

Deployment

Locally on dedicated hardware

Trigger for analysis

Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload

Processing time

1 - 10 minutes

Population

All brain MR

Market Presence

On market since

03-2020

AI Platforms

Resellers

Not specified

Countries present

1

Paying clinical customers

15

Research/test users

50

Pricing Information

Pricing model

One-off payment, Subscription

Based on

Pay-per-scan

Source: Vendor | First published: Jul 14, 2024 | Last updated: May 11, 2026